AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Octreotide in South Africa

10 products registered with SAHPRA — 8 active

Brand / ProductReg. No.HolderStatusExpires
OCTREOTIDE HEXAL 0,1 mgA40/34/0315HEXAL PHARMA (SA) (PTY) LTDsuspended18 Aug 2025
OCTREOTIDE HEXAL 0,05 mgA40/34/0314HEXAL PHARMA (SA) (PTY) LTDsuspended18 Aug 2025
SANDOSTATIN LAR 30 mg33/34/0241Novartis South Africa (Pty) Ltdactive1 Jan 1900
OCTREOTIDE TEVA 10 mg54/34/0425Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900
OCTREOTIDE TEVA 20 mg54/34/0426Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900
SANDOSTATIN LAR 10 mg33/34/0239Novartis South Africa (Pty) Ltdactive1 Jan 1900
SANDOSTATIN 0,05 mg/ml INJECTIONV/34/230Novartis South Africa (Pty) Ltdactive1 Jan 1900
SANDOSTATIN 0,1 mg INJECTIONV/34/231Novartis South Africa (Pty) Ltdactive1 Jan 1900
OCTREOTIDE TEVA 30 mg54/34/0427Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900
SANDOSTATIN LAR 20 mg33/34/0240Novartis South Africa (Pty) Ltdactive1 Jan 1900

Octreotide — SAHPRA Registration Details

SAHPRA (South Africa) has 10 registered products containing Octreotide, of which 8 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Octreotide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.